A retrospective analysis of BRAF-mutant NSCLC patients demonstrated an association of BRAF mutations, more significantly class II and III compared to class I, with brain metastasis in 29% of patients [44]. The gene discussed is BRAF; the disease is non-small cell lung carcinoma.